Search results
Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 hours agoIntra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than...
Cellular Fountain of Youth: New T-Cell Discovery Rewrites the Rules of Aging
SciTechDaily· 9 hours agoResearchers at St. Jude Children’s Research Hospital and the University of Minnesota have discovered...
Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
Clinical Trials Arena via Yahoo Finance· 19 hours agoIntra-Cellular Therapies has secured another win with positive topline results from a Phase III...
Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win
Investor's Business Daily· 16 hours agoIntra-Cellular Therapies is staring down a $1.7 billion opportunity in depression treatment, an...
Cellular Railroads Guide Healing in the Human Body
SciTechDaily· 3 hours agoResearchers discovered that specific cells in the human body travel in trains or clusters to repair tissues, guided by a feature called polarity. A new...
Samsung would hate the way I use my Galaxy Z Flip 5
Digital Trends via Yahoo News· 8 minutes agoI've been using the Samsung Galaxy Z Flip 5 again, and although it folds and unfolds, I've been ignoring that feature. I don't think Samsung would...
Intra-Cellular depression drug succeeds in second late-stage study
BioPharma Dive via Yahoo Finance· 1 day agoThe results position the company to unlock what’s believed to be a multibillion-dollar sales...
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study - Intra-Cellular...
Benzinga· 22 hours agoTuesday, Intra-Cellular Therapies Inc ITCI released topline results from Study 502 evaluating...
What's Driving Intra-Cellular Therapies Inc's Surprising 15% Sto
Guru Focus· 20 hours agoIntra-Cellular Therapies Inc (ITCI, Financial), a prominent player in the biopharmaceutical industry, has recently witnessed a significant uptick in its stock performance.
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $78.00
ETF DAILY NEWS· 6 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its price objective raised by JPMorgan Chase & Co. from $75.00 to $78.00 in a research report report published on ...